Measured Wealth Private Client Group, LLC Amgen Inc Transaction History

Measured Wealth Private Client Group, LLC

$307 Million
Q4 2024

A detailed history of Measured Wealth Private Client Group, LLC transactions in Amgen Inc stock. As of the latest transaction made, Measured Wealth Private Client Group, LLC holds 909 shares of AMGN stock, worth $264,664. This represents 0.08% of its overall portfolio holdings.

Number of Shares

909

Previous 901 0.89%

Holding current value

$264,664

Previous $290,000 18.62%

% of portfolio

0.08%

Previous 0.1%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 27, 2025	BUY	$258.78 - $328.31 $2,070 - $2,626	8 Added 0.89%	909 $236,000
Q3 2024 Oct 25, 2024	SELL	$309.38 - $337.38 $97,145 - $105,937	-314 Reduced 25.84%	901 $290,000
Q2 2024 Aug 12, 2024	BUY	$262.75 - $319.31 $1,051 - $1,277	4 Added 0.33%	1,215 $379,000
Q1 2024 Apr 18, 2024	BUY	$268.87 - $324.56 $9,141 - $11,035	34 Added 2.89%	1,211 $344,000
Q3 2023 Oct 18, 2023	SELL	$218.65 - $271.46 $10,713 - $13,301	-49 Reduced 4.0%	1,177 $316,000
Q2 2023 Jul 20, 2023	BUY	$214.27 - $253.37 $7,713 - $9,121	36 Added 3.03%	1,226 $272,000
Q1 2023 May 01, 2023	SELL	$225.79 - $275.2 $1,580 - $1,926	-7 Reduced 0.58%	1,190 $287,000
Q3 2022 Oct 27, 2022	SELL	$224.46 - $253.15 $27,384 - $30,884	-122 Reduced 9.25%	1,197 $270,000
Q2 2022 Jul 25, 2022	SELL	$230.71 - $256.74 $20,533 - $22,849	-89 Reduced 6.32%	1,319 $321,000
Q1 2022 May 03, 2022	SELL	$219.27 - $242.57 $181,774 - $201,090	-829 Reduced 37.06%	1,408 $341,000
Q4 2021 Jan 28, 2022	BUY	$198.88 - $227.6 $795 - $910	4 Added 0.18%	2,237 $503,000
Q3 2021 Nov 01, 2021	SELL	$212.27 - $248.7 $33,963 - $39,792	-160 Reduced 6.69%	2,233 $475,000
Q2 2021 Aug 05, 2021	BUY	$233.58 - $259.14 $119,359 - $132,420	511 Added 27.15%	2,393 $583,000
Q1 2021 May 04, 2021	BUY	$221.91 - $258.6 $98,084 - $114,301	442 Added 30.69%	1,882 $468,000
Q4 2020 Jan 20, 2021	BUY	$216.38 - $257.67 $14,497 - $17,263	67 Added 4.88%	1,440 $331,000
Q3 2020 Oct 15, 2020	BUY	$234.65 - $260.95 $93,156 - $103,597	397 Added 40.68%	1,373 $349,000
Q2 2020 Aug 03, 2020	BUY	$197.81 - $242.74 $193,062 - $236,914	976 New	976 $230,000
Q3 2019 Oct 11, 2019	SELL	$174.11 - $208.62 $208,932 - $250,344	-1,200 Closed	0 $0
Q2 2019 Jul 26, 2019	SELL	$166.7 - $195.41 $10,335 - $12,115	-62 Reduced 4.91%	1,200 $221,000
Q1 2019 May 07, 2019	BUY	$180.87 - $203.88 $228,257 - $257,296	1,262 New	1,262 $240,000
Q4 2018 Feb 07, 2019	SELL	$178.4 - $208.25 $239,056 - $279,055	-1,340 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $1,482 - $1,671	8 Added 0.6%	1,340 $278,000
Q2 2018 Aug 14, 2018	BUY	$166.05 - $186.51 $221,178 - $248,431	1,332 New	1,332 $245,000

Others Institutions Holding AMGN

# of Institutions

3,144

Shares Held

415M

Call Options Held

8.2M

Put Options Held

6.65M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $156B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Measured Wealth Private Client Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Measured Wealth Private Client Group, LLC with notifications on news.

Account

Measured Wealth Private Client Group, LLC Amgen Inc Transaction History